Vitamin D and Mortality Risk in Chronic Kidney Disease
- 22 September 2016
- book chapter
- Published by Springer Nature
- p. 405-420
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Oral active vitamin D is associated with improved survival in hemodialysis patientsKidney International, 2008
- Association of Oral Calcitriol with Improved Survival in Nondialyzed CKDJournal of the American Society of Nephrology, 2008
- Association of Activated Vitamin D Treatment and Mortality in Chronic Kidney DiseaseArchives of internal medicine (1960), 2008
- Vitamin D levels and early mortality among incident hemodialysis patientsKidney International, 2007
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Mortality risk among hemodialysis patients receiving different vitamin D analogsKidney International, 2006
- Activated Injectable Vitamin D and Hemodialysis SurvivalJournal of the American Society of Nephrology, 2005
- Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol TherapyNew England Journal of Medicine, 2003
- Action of 1,25-Dihydroxycholecalciferol, a Potent, Kidney-Produced Metabolite of Vitamin D3, in Uremic ManNew England Journal of Medicine, 1972
- Identification of 1,25-Dihydroxycholecalciferol, a Form of Vitamin D 3 Metabolically Active in the IntestineProceedings of the National Academy of Sciences, 1971